Find clinical trials for Diabetes in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near New Haven, CT, USA:
The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...
Phase 4
New Haven, Connecticut, United States and 9 other locations
for youth 10 to \<18 years old with newly diagnosed stage 3 type 1 diabetes (T1D). The study will also evaluate the effect of an Afrezza plu...
Phase 2
New Haven, Connecticut, United States and 9 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Bridgeport, Connecticut, United States of America and 89 other locations
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Waterbury, Massachusetts, United States of America and 40 other locations
The primary objective of this study is to demonstrate that KAI-9531 subcutaneous (SC) injection once weekly is superior to placebo on:* Percent chang...
Phase 3
Stamford, Connecticut, United States and 57 other locations
This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple a...
Phase 1, Phase 2
Syosset, New York, United States and 33 other locations
in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how...
Phase 3
Stamford, Connecticut, United States and 70 other locations
can improve patient outcomes for people over the age of 50 with diabetic foot ulcers. The study aims to determine the incidence of complete ...
Darien, Connecticut, United States and 7 other locations
The purpose of this research study is to test a mindfulness app called Calm Health among young adults with type 1 diabetes or other absolute...
New Haven, Connecticut, United States
control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...
Phase 2
New Haven, Connecticut, United States and 29 other locations
Clinical trials
Research sites
Resources
Legal